Gland Pharma appoints incumbent MD & CEO Srinivas Sadu as Executive Chairman & CEO

BL Hyderabad Bureau Updated - June 08, 2024 at 12:13 PM.
Srinivas Sadu, Managing Director & Chief Executive Officer of Gland Pharma

HyderabadGland Pharma has on Friday announced the appointment of Srinivas Sadu, the incumbent Managing Director (MD) and CEO, as Executive Chairman and CEO of the company, effective June 10, 2024. 

Srinivas Sadu, a seasoned professional with over two decades of experience, has been a key part of Gland Pharma’s journey. 

He assumed the role of MD and CEO on April 25, 2019, and has played a part in the company’s growth and success. His career with the company began in 2000, and he steadily rose through the ranks to become chief operating officer in 2011, according to a release. 

Sign up for newsletters, unlock features and do more on The Hindu
LOG IN
Support our reporting.
SUBSCRIBE NOW
Published on June 8, 2024 06:43
Tags

This is a Premium article available exclusively to our subscribers.

Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...

Subscribe
If you're already a subscriber
Access just this article

You have reached your free article limit.

Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...

Subscribe
If you're already a subscriber
Access just this article

You have reached your free article limit.
Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...

Subscribe
or read this article by Downloading TheHindu Businessline News app
If you're already a subscriber
Access just this article

TheHindu Businessline operates by its editorial values to provide you quality journalism.

Support our reporting.
Subscribe
This is your last free article.
to read unlimited content from TheHindu Businessline
Subscribe
Stay updated on Markets,Economy, Agri & more.
Get TheHindu Businessline News App on
Recommended Articles